All Weight Gain is Not the Same: Fatty Liver Disease in People with HIV
Release date: December 9, 2021
Expiration date: December 9, 2022
Estimated time to complete activity: 1.5 hours
Jointly provided by Postgraduate Institute for Medicine and American Academy of HIV Medicine.
This activity is supported by an independent education grant from Theratechnologies.
This activity has been designed to meet the educational needs of physicians, physician assistants, nurse practitioners, pharmacists, and registered nurses; other healthcare providers, such as nutritionists, social workers, and case managers are also encouraged to attend.
John R. Koethe MD, MSCI, FIDSA
Associate Professor of Medicine
Division of Infectious Diseases
Vanderbilt University Medical Center
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact house (0.5 APRN credit hours).
Type of Activity: Knowledge
Fee Information: There is no fee for this educational activity.
Method of Participation and Request for Credit
In order to obtain your CE certificate, please follow the steps below at the conclusion of the activity:
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The planners and their spouses/partners wish to disclose they have no financial interests or other relationships with any ACCME-defined ineligible companies.
Dr. Koethe has served as a consultant to Merck & Co., Gilead Sciences, ViiV Healthcare, Janssen Pharmaceuticals and Theratechnologies, and received research support from Merck & Co. and Gilead Sciences.
Hardware and Software Requirements
AAHIVM.org requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
If you have questions regarding the certification of this activity, please contact PIM via email at email@example.com.